Latest & greatest articles for side effects

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on side effects or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on side effects and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for side effects

101. Rare post prostatectomy side effects: a systematic review

Rare post prostatectomy side effects: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures Timing (...) and effect measures Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Context and rationale Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Example: Screening will be performed in two phases, namely initial screening based on title and abstract, followed by full-text screening of the eligible articles for final

2013 PROSPERO

102. Systematic review of the incidence of Erythema multiforme as a side effect of using nevirapine as an agent in highly active antiretroviral treatment

Systematic review of the incidence of Erythema multiforme as a side effect of using nevirapine as an agent in highly active antiretroviral treatment Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith (...) " or "Joanne") for correspondence: Organisation web address: Timing and effect measures Timing and effect measures Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Context and rationale Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Example: Screening will be performed in two phases, namely initial screening

2013 PROSPERO

103. Mefloquine: strengthened warnings on neuropsychiatric side effects

Mefloquine: strengthened warnings on neuropsychiatric side effects Mefloquine: strengthened warnings on neuropsychiatric side effects - GOV.UK GOV.UK uses cookies to make the site simpler. or Search Mefloquine: strengthened warnings on neuropsychiatric side effects A recent review of the prescribing information has led to strengthened warnings and new measures to help minimise risks. To minimise the risk of these adverse reactions, mefloquine must not be used for chemoprophylaxis in patients (...) name Lariam) is used for prophylaxis and treatment of Plasmodium falciparum malaria. Official guidance on the appropriate use of antimalarial medicines and the prevalence of resistance should be considered when prescribing mefloquine (see further information links below). Although the potential for neuropsychiatric side effects with mefloquine is a well-established risk, a recent review of the prescribing information has led to strengthened warnings and new measures to help minimise risks

2013 MHRA Drug Safety Update

104. Systematic review with meta-analysis: Topical NSAIDS provide effective pain relief for patients with hand or knee osteoarthritis with similar efficacy, and fewer side effects, than oral NSAIDS Full Text available with Trip Pro

Systematic review with meta-analysis: Topical NSAIDS provide effective pain relief for patients with hand or knee osteoarthritis with similar efficacy, and fewer side effects, than oral NSAIDS Topical NSAIDS provide effective pain relief for patients with hand or knee osteoarthritis with similar efficacy, and fewer side effects, than oral NSAIDS | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie (...) relief for patients with hand or knee osteoarthritis with similar efficacy, and fewer side effects, than oral NSAIDS Article Text Therapeutics Systematic review with meta-analysis Topical NSAIDS provide effective pain relief for patients with hand or knee osteoarthritis with similar efficacy, and fewer side effects, than oral NSAIDS Andrew Östör , Pippa A Watson Statistics from Altmetric.com Commentary on: Derry S , Moore RA , Rabbie R . Topical NSAIDs for chronic musculoskeletal pain in adults

2013 Evidence-Based Medicine

105. No difference in extrapyramidal side effects between first-generation and second-generation antipsychotics

No difference in extrapyramidal side effects between first-generation and second-generation antipsychotics No difference in extrapyramidal side effects between first-generation and second-generation antipsychotics | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password (...) For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here No difference in extrapyramidal side effects between first-generation and second-generation antipsychotics Article Text Therapeutics No difference in extrapyramidal side effects

2012 Evidence-Based Mental Health

106. Review: extrapyramidal side effects vary between different second-generation antipsychotic drugs

Review: extrapyramidal side effects vary between different second-generation antipsychotic drugs Review: extrapyramidal side effects vary between different second-generation antipsychotic drugs | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts (...) OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: extrapyramidal side effects vary between different second-generation antipsychotic drugs Article Text Therapeutics Review: extrapyramidal side effects vary between different second-generation

2012 Evidence-Based Mental Health

107. Effects of Amplification on Quality of Life Among School Age Children with Single Sided Deafness

Effects of Amplification on Quality of Life Among School Age Children with Single Sided Deafness Copyright © 2011 Cincinnati Children's Hospital Medical Center; all rights reserved Page 1 of 5 Audiology/Single Sided Deafness/Amplification/BESt 104 Best Evidence Statement (BESt) Date published/posted 6/20/11 Topic: Effects of Amplification on Quality of Life Among School Age Children with Single Sided Deafness Clinical Question P: Among school age children with single sided deafness I: does (...) be offered (Hol, 2010 [3b], Christensen, 2010 [4a], House 2010 [3a]). Note 1: Selected educational and family outcomes are important to monitor when amplification is used or if a decision is made not to provide amplification (McKay 2010 [5a]). Note 2: Utilize Quality of Life measurements with any child identified with SSD and their families (Borton 2010 [3a]). Note 3: Educate parents/families and the child on the impact of single sided deafness regarding the potential effects of the hearing loss, current

2011 Cincinnati Children's Hospital Medical Center

108. Side effects of interferon treatment for hepatitis patients: a systematic review

Side effects of interferon treatment for hepatitis patients: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing (...) and effect measures Timing and effect measures Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Context and rationale Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Example: Screening will be performed in two phases, namely initial screening based on title and abstract, followed by full-text screening

2011 PROSPERO

109. Review: metabolic side effects of second-generation antipsychotics

Review: metabolic side effects of second-generation antipsychotics Review: metabolic side effects of second-generation antipsychotics | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password (...) * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: metabolic side effects of second-generation antipsychotics Article Text Therapeutics Review: metabolic side effects of second-generation antipsychotics Statistics from Altmetric.com Question Question To what extent do second-generation

2011 Evidence-Based Mental Health

110. No differences in efficacy of atypical and typical antipsychotics in early psychosis, but side effects differ

No differences in efficacy of atypical and typical antipsychotics in early psychosis, but side effects differ No differences in efficacy of atypical and typical antipsychotics in early psychosis, but side effects differ | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here No differences in efficacy of atypical and typical antipsychotics in early psychosis, but side effects differ Article Text Therapeutics No differences in efficacy

2011 Evidence-Based Mental Health

111. Antidepressant non-adherence is common among veterans, with ineffectiveness and side effects as commonly reported reasons

Antidepressant non-adherence is common among veterans, with ineffectiveness and side effects as commonly reported reasons Antidepressant non-adherence is common among veterans, with ineffectiveness and side effects as commonly reported reasons | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using (...) your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Antidepressant non-adherence is common among veterans, with ineffectiveness and side effects as commonly reported reasons Article Text Prevalence

2011 Evidence-Based Mental Health

112. Patients with cancer believed that chemotherapy had to ?hurt? or ?cause side effects? to be effective

Patients with cancer believed that chemotherapy had to ?hurt? or ?cause side effects? to be effective Patients with cancer believed that chemotherapy had to “hurt” or “cause side effects” to be effectiveCommentary | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password (...) For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Patients with cancer believed that chemotherapy had to “hurt” or “cause side effects” to be effectiveCommentary Article Text Qualitative Patients with cancer believed

2010 Evidence-Based Nursing

113. A Systematic Review of Side Effects of Nucleoside and Nucleotide Drugs Used for Treatment of Chronic Hepatitis B. Full Text available with Trip Pro

A Systematic Review of Side Effects of Nucleoside and Nucleotide Drugs Used for Treatment of Chronic Hepatitis B. Although nucleosides and nucleotides have a good safety record for the treatment of hepatitis B, there have been no systematic reviews on this topic. We searched Medline to include studies of the oral antiviral agents for hepatitis B and adverse events, with at least 48 weeks of follow-up from the initiation of treatment with the drug. Important toxicities include nephrotoxicity (...) , myopathy, and resistance. It is often difficult to ascertain whether an adverse effect is from the study drug or the natural progression of the disease. Further safety data are needed for the newer agents and for all agents with regard to patients with decompensated liver disease, renal dysfunction, the elderly, children, and pregnant women.

2010 Current hepatitis reports

114. Incisional continuous fascia iliaca block provides more effective pain relief and fewer side effects than opioids after pelvic osteotomy in children Full Text available with Trip Pro

Incisional continuous fascia iliaca block provides more effective pain relief and fewer side effects than opioids after pelvic osteotomy in children Intravenous opioid therapy is frequently used for postoperative pain management in children after orthopedic surgery but causes side effects such as respiratory depression, vomiting, sedation, and urinary retention. To investigate whether a continuous incisional fascia iliaca compartment (FIC) block provides more effective postoperative pain relief (...) with fewer side effects than IV morphine, we performed a prospective, double-blind, randomized study to compare both techniques.Thirty children (ASA physical status I-II) aged 3 mo to 6 yr undergoing a pelvic osteotomy were included in the study. The children were randomized for either morphine IV and placebo (saline) via a FIC catheter (Group M) or placebo (saline) IV and ropivacaine via a FIC catheter (Group R). All patients received general anesthesia using inhaled sevoflurane and IV fentanyl

2010 EvidenceUpdates Controlled trial quality: predicted high

115. Ocular side effects of Topiramate: Frequently asked questions

Ocular side effects of Topiramate: Frequently asked questions The Royal College of Ophthalmologists Ocular side effects of Topiramate- Frequently asked questions 1. What is Topiramate and when is it indicated clinically? Topiramate is a sulfamate-substituted monosaccharide derived from D-fructose. Its is used mainly as an antiepileptic drug both as mono-therapy and as an adjunct in the control of partial and primary generalised epilepsy in adults and children above the age of two 1-3 (...) collected from spontaneous reporting systems have identified one hundred and fifteen cases of ocular side effects which include acute-onset angle closure glaucoma, acute myopia, suprachoriodal effusions, peri-orbital oedema, scleritis, blepharospasm, oculogyric crisis, nystagmus and diplopia 16 . 4. Which patients develop Acute Angle Closure Glaucoma? (AACG) The mean age of occurrence of secondary AACG is 34 years with a range between 3 years and 70 years. The condition has predominantly been reported

2010 Royal College of Ophthalmologists

116. Review of the Ocular side effects of Topiramate

Review of the Ocular side effects of Topiramate RCOphth reference: 2010/PROF/122 Original document 2006 Reviewed October 2010 1 A Review of the Ocular side effects of Topiramate Author: Patrick Watts This manuscript was reviewed by Paediatric Ophthalmology Subcommittee, Royal College of Ophthalmologists Address for Correspondence: Mr Patrick Watts Department of Ophthalmology University Hospital of Wales Cardiff CF14 4XW Telephone: (+44) 2920748583 Fax: (+44) 2920748240 Keywords: Topiramate (...) , Glaucoma RCOphth reference: 2010/PROF/122 Original document 2006 Reviewed October 2010 2 Abstract Acute angle closure glaucoma and visual blurring due to induced myopia have been reported with the use of the antiepileptic drug topiramate. Various hypotheses have been put forward to explain the mechanism of the aforementioned ocular side effects. These presumed ocular side effects of topiramate have included patients treated with other drugs such as serotonin reuptake inhibitors which are also reported

2010 Royal College of Ophthalmologists

117. Paracetamol and selective and non-selective non-steroidal anti-inflammatory drugs (NSAIDs) for the reduction of morphine-related side-effects after major surgery: a systematic review

Paracetamol and selective and non-selective non-steroidal anti-inflammatory drugs (NSAIDs) for the reduction of morphine-related side-effects after major surgery: a systematic review Paracetamol and selective and non-selective non-steroidal anti-inflammatory drugs (NSAIDs) for the reduction of morphine-related side-effects after major surgery: a systematic review Paracetamol and selective and non-selective non-steroidal anti-inflammatory drugs (NSAIDs) for the reduction of morphine-related side (...) side-effects after major surgery: a systematic review. Health Technology Assessment 2010; 14(17): 1-94 Authors' conclusions Study found no strong case for routine addition of paracetamol, non-steroidal anti-inflammatory drugs or cyclo-oxygenase inhibitors to patient-controlled administered morphine to reduce morphine consumption and associated adverse effects in the 24 hours following major surgery Project page URL URL for DARE abstract INAHTA brief and checklist Indexing Status Subject indexing

2010 Health Technology Assessment (HTA) Database.

118. Side effects of phytoestrogens: a meta-analysis of randomized trials (Abstract)

Side effects of phytoestrogens: a meta-analysis of randomized trials Phytoestrogens are widely used by postmenopausal women for the treatment of the climacteric syndrome. The risk of adverse effects of this treatment, however, is unknown.Using a fixed-effects model, we performed a meta-analysis of side effects comparing phytoestrogen treatment with placebo or no treatment in randomized controlled trials.We identified 174 randomized controlled trials. Side effects were reported in 92/174 (...) randomized controlled trials with 9629 participants. The overall incidence of side effects in the phytoestrogen and control groups was 2019/5502 (36.7%) and 1824/4806 (38.0%), respectively (P=.2; incidence rate ratio [IRR] 1.01; 95% confidence interval [CI], 0.95-1.08). Comparing various side effect categories, we found significantly higher rates of gastrointestinal side effects among phytoestrogen users (P=.003; IRR 1.28; 95% CI, 1.08-1.50). Gynecological (IRR 0.94; 95% CI, 0.74-1.20), musculoskeletal

2010 EvidenceUpdates

119. Side effects of methylphenidate in childhood cancer survivors: a randomized placebo-controlled trial Full Text available with Trip Pro

Side effects of methylphenidate in childhood cancer survivors: a randomized placebo-controlled trial To investigate the frequency and severity of side effects of methylphenidate among childhood survivors of acute lymphoblastic leukemia and brain tumors and identify predictors of higher adverse effect levels.Childhood cancer survivors (N = 103) identified as having attention and learning problems completed a randomized, double-blind, 3-week, home-crossover trial of placebo, low-dose (...) methylphenidate (0.3 mg/kg; 10 mg twice daily maximum) and moderate-dose methylphenidate (0.6 mg/kg; 20 mg twice daily maximum). Caregivers completed the Barkley Side Effects Rating Scale (SERS) at baseline and each week during the medication trial. Siblings of cancer survivors (N = 49) were recruited as a healthy comparison group.There was a significantly higher number and severity of symptoms endorsed on the SERS when patients were taking moderate dose compared with placebo or low dose, but not low dose

2009 EvidenceUpdates Controlled trial quality: uncertain

120. Systematic review and metaanalysis of statins for heterozygous familial hypercholesterolemia in children: evaluation of cholesterol changes and side effects

Systematic review and metaanalysis of statins for heterozygous familial hypercholesterolemia in children: evaluation of cholesterol changes and side effects Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.